These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 33127878)

  • 1. Age-related cerebral small vessel disease and inflammaging.
    Li T; Huang Y; Cai W; Chen X; Men X; Lu T; Wu A; Lu Z
    Cell Death Dis; 2020 Oct; 11(10):932. PubMed ID: 33127878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Immunosenescence in Cerebral Small Vessel Disease: A Review.
    Del Cuore A; Pacinella G; Riolo R; Tuttolomondo A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of Immunosenescence in Cerebral Small Vessel Disease.
    Jian B; Hu M; Cai W; Zhang B; Lu Z
    Front Immunol; 2020; 11():585655. PubMed ID: 33362768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invited Review: The spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies.
    Schreiber S; Wilisch-Neumann A; Schreiber F; Assmann A; Scheumann V; Perosa V; Jandke S; Mawrin C; Carare RO; Werring DJ
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):219-239. PubMed ID: 31386773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease.
    Zhang CE; Wong SM; van de Haar HJ; Staals J; Jansen JF; Jeukens CR; Hofman PA; van Oostenbrugge RJ; Backes WH
    Neurology; 2017 Jan; 88(5):426-432. PubMed ID: 28031395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging.
    Zhang CE; Wong SM; Uiterwijk R; Backes WH; Jansen JFA; Jeukens CRLPN; van Oostenbrugge RJ; Staals J
    Brain Imaging Behav; 2019 Apr; 13(2):389-395. PubMed ID: 29572621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies.
    Cuadrado-Godia E; Dwivedi P; Sharma S; Ois Santiago A; Roquer Gonzalez J; Balcells M; Laird J; Turk M; Suri HS; Nicolaides A; Saba L; Khanna NN; Suri JS
    J Stroke; 2018 Sep; 20(3):302-320. PubMed ID: 30309226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of Immunity in Cerebral Small Vessel Disease.
    Fu Y; Yan Y
    Front Immunol; 2018; 9():67. PubMed ID: 29422904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI phenotyping of underlying cerebral small vessel disease in mixed hemorrhage patients.
    Scheumann V; Schreiber F; Perosa V; Assmann A; Mawrin C; Garz C; Heinze HJ; Görtler M; Düzel E; Vielhaber S; Charidimou A; Schreiber S
    J Neurol Sci; 2020 Dec; 419():117173. PubMed ID: 33068905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.
    Fernandes R; Viana SD; Nunes S; Reis F
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1876-1897. PubMed ID: 30287404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier.
    Semyachkina-Glushkovskaya O; Postnov D; Penzel T; Kurths J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Related Hearing Loss: The Link between Inflammaging, Immunosenescence, and Gut Dysbiosis.
    Kociszewska D; Vlajkovic S
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging.
    Thomas R; Wang W; Su DM
    Immun Ageing; 2020; 17():2. PubMed ID: 31988649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A narrative review on inflammaging and late-onset hypogonadism.
    Xing D; Jin Y; Jin B
    Front Endocrinol (Lausanne); 2024; 15():1291389. PubMed ID: 38298378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis.
    Livshits G; Kalinkovich A
    Ageing Res Rev; 2019 Dec; 56():100980. PubMed ID: 31726228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral small vessel disease: A review.
    Chojdak-Łukasiewicz J; Dziadkowiak E; Zimny A; Paradowski B
    Adv Clin Exp Med; 2021 Mar; 30(3):349-356. PubMed ID: 33768739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heavy Metal-Induced Cerebral Small Vessel Disease: Insights into Molecular Mechanisms and Possible Reversal Strategies.
    Patwa J; Flora SJS
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Small Vessel Disease: a Review of the Pathophysiological Mechanisms.
    Hannawi Y
    Transl Stroke Res; 2024 Dec; 15(6):1050-1069. PubMed ID: 37864643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary cerebral small-vessel disease].
    Nozaki H; Nishizawa M; Onodera O
    Nihon Rinsho; 2013 Mar; 71(3):545-54. PubMed ID: 23631251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral small vessel disease, cognitive reserve and cognitive dysfunction.
    Pinter D; Enzinger C; Fazekas F
    J Neurol; 2015 Nov; 262(11):2411-9. PubMed ID: 25976029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.